• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行期间门诊血液透析的管理:加拿大肾脏病学会2019冠状病毒病快速反应小组的建议

Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.

作者信息

Suri Rita S, Antonsen John E, Banks Cheryl A, Clark David A, Davison Sara N, Frenette Charles H, Kappel Joanne E, MacRae Jennifer M, Mac-Way Fabrice, Mathew Anna, Moist Louise M, Qirjazi Elena, Tennankore Karthik K, Vorster Hans

机构信息

Division of Nephrology, Department of Medicine/Research Institute, McGill University, Montreal, QC, Canada.

Centre de recherche de l'Université de Montréal, Montreal, QC, Canada.

出版信息

Can J Kidney Health Dis. 2020 Sep 11;7:2054358120938564. doi: 10.1177/2054358120938564. eCollection 2020.

DOI:10.1177/2054358120938564
PMID:32963790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7488889/
Abstract

PURPOSE

To collate best practice recommendations on the management of patients receiving in-center hemodialysis during the COVID-19 pandemic, based on published reports and current public health advice, while considering ethical principles and the unique circumstances of Canadian hemodialysis units across the country.

SOURCES OF INFORMATION

The workgroup members used Internet search engines to retrieve documents from provincial and local hemodialysis programs; provincial public health agencies; the Centers for Disease Control and Prevention; webinars and slides from other kidney agencies; and nonreviewed preprints. PubMed was used to search for peer-reviewed published articles. Informal input was sought from knowledge users during a webinar.

METHODS

Challenges in the care of hemodialysis patients during the COVID-19 pandemic were highlighted within the Canadian Senior Renal Leaders Forum discussion group. The Canadian Society of Nephrology (CSN) developed the COVID-19 rapid response team (RRT) to address these challenges. They identified a pan-Canadian team of clinicians and administrators with expertise in hemodialysis to form the workgroup. One lead was chosen who drafted the initial document. Members of the workgroup reviewed and discussed all recommendations in detail during 2 virtual meetings on April 7 and April 9. Disagreements were resolved by consensus. The document was reviewed by the CSN COVID-19 RRT, an ethicist, an infection control expert, a community nephrologist, and a patient partner. Content was presented during an interactive webinar on April 11, 2020 attended by 269 kidney health professionals, and the webinar and first draft of the document were posted online. Final revisions were made based on feedback received until April 13, 2020. CJKHD editors reviewed the parallel process peer review and edited the manuscript for clarity.

KEY FINDINGS

Recommendations were made under the following themes: (1) Identification of patients with COVID-19 in the dialysis unit, (2) hemodialysis of patients with confirmed COVID-19, (3) hemodialysis of patients not yet known to have COVID-19, (4) visitors; (5) testing for COVID-19 in the dialysis unit; (6) resuscitation, (6) routine hemodialysis care, (7) hemodialysis care under fixed dialysis resources.

LIMITATIONS

Because of limitations of time and resources, and the large number of questions, formal systematic review was not undertaken. The recommendations are based on expert opinion and subject to bias. The parallel review process that was created may not be as robust as the standard peer review process.

IMPLICATIONS

We hope that these recommendations provide guidance for dialysis unit directors, clinicians, and administrators on how to limit risk from infection and adverse outcomes, while providing necessary dialysis care in a setting of finite resources. We also identify a number of resource allocation priorities, which we hope will inform decisions at provincial funding agencies.

摘要

目的

基于已发表的报告和当前的公共卫生建议,整理关于2019冠状病毒病大流行期间接受中心血液透析患者管理的最佳实践建议,同时考虑伦理原则以及加拿大全国血液透析单位的特殊情况。

信息来源

工作组成员使用互联网搜索引擎检索来自省级和地方血液透析项目、省级公共卫生机构、疾病控制与预防中心、其他肾脏机构的网络研讨会和幻灯片以及未经审核的预印本的文件。使用PubMed搜索同行评审的已发表文章。在一次网络研讨会上征求了知识使用者的非正式意见。

方法

加拿大高级肾脏领导人论坛讨论组强调了2019冠状病毒病大流行期间血液透析患者护理中的挑战。加拿大肾脏病学会(CSN)组建了2019冠状病毒病快速反应团队(RRT)来应对这些挑战。他们确定了一个由具有血液透析专业知识的临床医生和管理人员组成的全加拿大团队来组建工作组。选出一名负责人起草初始文件。工作组的成员在4月7日和4月9日的2次虚拟会议上详细审查并讨论了所有建议。通过协商一致解决分歧。该文件由CSN的2019冠状病毒病RRT、一名伦理学家、一名感染控制专家、一名社区肾病学家和一名患者代表进行了审查。相关内容在2020年4月11日由269名肾脏健康专业人员参加的互动网络研讨会上进行了展示,该网络研讨会和文件初稿已发布在网上。根据截至2020年4月1十三日收到的反馈进行了最终修订。《加拿大肾脏健康与疾病杂志》(CJKHD)编辑审查了并行同行评审过程,并对手稿进行编辑以使其更清晰。

主要发现

在以下主题下提出了建议:(1)透析单位中2019冠状病毒病患者的识别,(2)确诊2019冠状病毒病患者的血液透析,(3)尚未知晓感染2019冠状病毒病患者的血液透析,(4)访客;(5)透析单位中的2019冠状病毒病检测;(6)复苏,(6)常规血液透析护理,(7)固定透析资源下的血液透析护理。

局限性

由于时间和资源的限制以及大量问题,未进行正式的系统评价。这些建议基于专家意见,可能存在偏差。所创建的并行评审过程可能不如标准的同行评审过程严格。

启示

我们希望这些建议能为透析单位主任、临床医生和管理人员提供指导,告知他们如何在有限资源的情况下,在提供必要透析护理的同时降低感染风险和不良后果。我们还确定了一些资源分配优先事项,希望能为省级资助机构的决策提供参考。

相似文献

1
Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.2019冠状病毒病大流行期间门诊血液透析的管理:加拿大肾脏病学会2019冠状病毒病快速反应小组的建议
Can J Kidney Health Dis. 2020 Sep 11;7:2054358120938564. doi: 10.1177/2054358120938564. eCollection 2020.
2
Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group.2019冠状病毒病大流行期间小儿肾移植患者的管理:加拿大移植学会儿科组的指南
Can J Kidney Health Dis. 2020 Nov 13;7:2054358120967845. doi: 10.1177/2054358120967845. eCollection 2020.
3
Management of Advanced Chronic Kidney Disease During the COVID-19 Pandemic: Suggestions From the Canadian Society of Nephrology COVID-19 Rapid Response Team.2019冠状病毒病大流行期间晚期慢性肾脏病的管理:加拿大肾脏病学会2019冠状病毒病快速反应小组的建议
Can J Kidney Health Dis. 2020 Jul 19;7:2054358120939354. doi: 10.1177/2054358120939354. eCollection 2020.
4
Canadian Society of Nephrology COVID-19 Rapid Response Team Home Dialysis Recommendations.加拿大肾脏病学会COVID-19快速反应小组居家透析建议
Can J Kidney Health Dis. 2020 May 29;7:2054358120928153. doi: 10.1177/2054358120928153. eCollection 2020.
5
Canadian Association of Paediatric Nephrologists COVID-19 Rapid Response: Home and In-Center Dialysis Guidance.加拿大儿科肾脏病学家协会 COVID-19 快速响应:家庭与中心透析指南
Can J Kidney Health Dis. 2021 Nov 10;8:20543581211053458. doi: 10.1177/20543581211053458. eCollection 2021.
6
Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.2019冠状病毒病大流行期间肾小球肾炎患者的管理:加拿大肾脏病学会2019冠状病毒病快速反应小组的建议
Can J Kidney Health Dis. 2020 Nov 26;7:2054358120968955. doi: 10.1177/2054358120968955. eCollection 2020.
7
Canadian Association of Paediatric Nephrologists COVID-19 Rapid Response: Guidelines for Management of Acute Kidney Injury in Children.加拿大儿科肾脏病学家协会COVID-19快速响应:儿童急性肾损伤管理指南
Can J Kidney Health Dis. 2021 Feb 5;8:2054358121990135. doi: 10.1177/2054358121990135. eCollection 2021.
8
Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team.COVID-19大流行期间加拿大儿童肾小球疾病患者的管理:加拿大儿科肾脏病学家协会COVID-19快速反应小组的建议
Can J Kidney Health Dis. 2020 Nov 13;7:2054358120970713. doi: 10.1177/2054358120970713. eCollection 2020.
9
CSN COVID-19 Rapid Review Program: Management of Acute Kidney Injury.社区神经系统疾病新型冠状病毒肺炎快速审查项目:急性肾损伤的管理
Can J Kidney Health Dis. 2020 Jul 15;7:2054358120941679. doi: 10.1177/2054358120941679. eCollection 2020.
10
The CSN COVID-19 Rapid Response Program.国家自然科学委员会新冠疫情快速响应项目
Can J Kidney Health Dis. 2020 Oct 21;7:2054358120949110. doi: 10.1177/2054358120949110. eCollection 2020.

引用本文的文献

1
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection.瑞士透析人群中与2019冠状病毒病大流行相关的死亡率,不包括严重急性呼吸综合征冠状病毒2感染。
Clin Kidney J. 2024 Oct 29;17(12):sfae322. doi: 10.1093/ckj/sfae322. eCollection 2024 Dec.
2
The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey.2019冠状病毒病大流行对中心血液透析服务的全球影响:一项国际肾脏病学会-透析结果实践模式研究调查
Kidney Int Rep. 2022 Mar;7(3):397-409. doi: 10.1016/j.ekir.2021.12.011. Epub 2021 Dec 13.
3
Infection control measures to prevent outbreaks of COVID-19 in Quebec hemodialysis units: a cross-sectional survey.魁北克血液透析单位预防 COVID-19 爆发的感染控制措施:一项横断面调查。
CMAJ Open. 2021 Dec 21;9(4):E1232-E1241. doi: 10.9778/cmajo.20210102. Print 2021 Oct-Dec.
4
Canadian Association of Paediatric Nephrologists COVID-19 Rapid Response: Home and In-Center Dialysis Guidance.加拿大儿科肾脏病学家协会 COVID-19 快速响应:家庭与中心透析指南
Can J Kidney Health Dis. 2021 Nov 10;8:20543581211053458. doi: 10.1177/20543581211053458. eCollection 2021.
5
Changes in US Dialysis Dietitian Responsibilities and Patient Needs During the COVID-19 Pandemic.美国透析营养师在 COVID-19 大流行期间的职责变化和患者需求。
J Ren Nutr. 2022 Jan;32(1):112-119. doi: 10.1053/j.jrn.2021.07.006. Epub 2021 Jul 27.
6
The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review.《COVID-19 大流行时代血液透析患者的脆弱世界:系统范围界定综述》。
J Nephrol. 2021 Oct;34(5):1387-1403. doi: 10.1007/s40620-021-01136-5. Epub 2021 Aug 21.
7
Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.接受血液透析患者接种 1 剂 BNT162b2 疫苗后的短期抗体反应。
CMAJ. 2021 May 31;193(22):E793-E800. doi: 10.1503/cmaj.210673. Epub 2021 May 12.
8
The CSN COVID-19 Rapid Response Program.国家自然科学委员会新冠疫情快速响应项目
Can J Kidney Health Dis. 2020 Oct 21;7:2054358120949110. doi: 10.1177/2054358120949110. eCollection 2020.
9
Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study.年龄和多种合并症是血液透析 COVID-19 患者的不良预后因素:黎巴嫩国家研究。
BMC Nephrol. 2021 Feb 27;22(1):73. doi: 10.1186/s12882-021-02270-9.
10
COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.社区传播地区透析患者的2019冠状病毒病状况、症状负担及特征:研究信函
Can J Kidney Health Dis. 2020 Oct 14;7:2054358120964178. doi: 10.1177/2054358120964178. eCollection 2020.

本文引用的文献

1
Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis.武汉经验对降低长期血液透析患者感染新冠病毒风险的启示
Clin J Am Soc Nephrol. 2020 May 7;15(5):717-719. doi: 10.2215/CJN.03420320. Epub 2020 Apr 2.
2
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.慢性肾脏病与2019冠状病毒病(COVID-19)严重感染相关。
Int Urol Nephrol. 2020 Jun;52(6):1193-1194. doi: 10.1007/s11255-020-02451-9. Epub 2020 Mar 28.
3
Mitigating Risk of COVID-19 in Dialysis Facilities.降低透析机构中新冠病毒病的风险
Clin J Am Soc Nephrol. 2020 May 7;15(5):707-709. doi: 10.2215/CJN.03340320. Epub 2020 Mar 20.
4
Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres.血液透析中心预防、减轻和控制新型 SARS-CoV-2(COVID-19)大流行的建议。
Nephrol Dial Transplant. 2020 May 1;35(5):737-741. doi: 10.1093/ndt/gfaa069.
5
Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management.增量式和非频繁血液透析:透析起始和保守治疗的新范例
Panminerva Med. 2017 Jun;59(2):188-196. doi: 10.23736/S0031-0808.17.03299-2. Epub 2017 Jan 13.
6
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.新透析患者的递增式血液透析、残余肾功能与死亡风险:一项队列研究
Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9.
7
Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.两周三次和递增式血液透析治疗用于启动肾脏替代治疗。
Am J Kidney Dis. 2014 Aug;64(2):181-6. doi: 10.1053/j.ajkd.2014.04.019. Epub 2014 May 17.